Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 215328
Company: PADAGIS ISRAEL
Company: PADAGIS ISRAEL
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
BUDESONIDE | BUDESONIDE | 2MG/ACTUATION | AEROSOL, FOAM;RECTAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
04/12/2023 | ORIG-1 | Approval | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/215328Orig1s000ltr.pdf |
BUDESONIDE
AEROSOL, FOAM;RECTAL; 2MG/ACTUATION
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
BUDESONIDE | BUDESONIDE | 2MG/ACTUATION | AEROSOL, FOAM;RECTAL | Prescription | No | AB | 215328 | PADAGIS ISRAEL |
UCERIS | BUDESONIDE | 2MG/ACTUATION | AEROSOL, FOAM;RECTAL | Prescription | Yes | AB | 205613 | SALIX |